Los Angeles Capital Management
ENZN

Los Angeles Capital Management’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Los Angeles Capital Management’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-77,630
Closed -$80K – 1348
2014
Q1 		$80K Sell
77,630
-8,620
-10% -$8.9K ﹤0.01% 1232
2013
Q4 		$100K Buy
86,250
+10,510
+14% +$16.2K ﹤0.01% 1254
2013
Q3 		$127K Sell
75,740
-1,230
-2% -$2.28K ﹤0.01% 1277
2013
Q2 		$154K Buy
+76,970
New +$225K ﹤0.01% 1256

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Los Angeles Capital Management's ENZN Position: Q2 2014 in Review

Los Angeles Capital Management sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2014, closing a stake of 77,630 shares — an estimated $80K sold.

Los Angeles Capital Management first reported a position in ENZN in Q2 2013 and held it in 4 quarters. The position peaked at $154K in Q2 2013. 67 funds tracked by Wall St. Rank hold ENZN as of Q2 2014.

  • Los Angeles Capital Management reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • Los Angeles Capital Management sold 77,630 ENZON PHARMACEUTICALS INC shares in Q2 2014, an estimated $80K.
  • Los Angeles Capital Management first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 4 quarters.
  • Los Angeles Capital Management's ENZON PHARMACEUTICALS INC position peaked at $154K in Q2 2013.
  • 67 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2014.

Based on Los Angeles Capital Management's 13F filing for Q2 2014, filed 12 Aug 2014.